Vestibular Schwannoma Surgery Facial Nerve Outcomes

🟢
Peer-Reviewed Research

Postoperative facial nerve palsy occurred in a significant number of patients after surgery for large vestibular schwannomas, but anatomical nerve preservation was successfully achieved in 87.5% of cases. A new study of 130 patients who underwent tumor removal via a specific surgical approach provides detailed data on the balance between removing these challenging growths and protecting critical cranial nerve function.

Key Takeaways

  • In a study of 130 patients with cerebellopontine angle vestibular schwannomas, surgeons achieved anatomical preservation of the facial nerve in 87.5% of cases using the retromastoid retrosigmoid sub-occipital approach.
  • Complete tumor removal was accomplished in 92.3% of patients, most of whom had large tumors causing significant symptoms like cerebellar ataxia (84.6%) and raised intracranial pressure (46.15%).
  • Hearing preservation was possible in only 6.2% of patients, highlighting the extreme difficulty of saving hearing function when dealing with large tumors in this location.
  • The findings confirm that facial nerve palsy remains a common and impactful complication of this surgery, directly affecting a patient’s quality of life through impaired facial movement and expression.

## A Focus on Large, Symptomatic Tumors
Researchers Soumen Samadder, Shuvra Mandol, and Kazi Hafiz Uddin conducted a retrospective analysis of 130 patients who underwent surgical resection for cerebellopontine angle (CPA) vestibular schwannoma at their institution between January 2017 and May 2022. The cohort primarily consisted of patients with advanced disease. A large majority (75.38%) had no useful hearing remaining before surgery, 84.61% presented with disabling cerebellar ataxia affecting balance and coordination, and nearly half (46.15%) showed features of raised intracranial pressure. All surgeries were performed using the retromastoid retrosigmoid sub-occipital approach, a common route to the posterior fossa that aims for maximal tumor removal while protecting neurological structures.

## Measuring Facial Nerve and Hearing Outcomes
The team used standardized tools to measure patient outcomes. Postoperative facial nerve function was assessed with the House-Brackmann (HB) grading system, which classifies facial palsy from grade I (normal function) to grade VI (total paralysis). This allowed the researchers to track the incidence, severity, and recovery patterns of facial weakness. Hearing function was evaluated using pure tone audiometry before and after the operation. The primary goals were to analyze how often facial nerve palsy occurred after this specific surgical approach and to identify factors related to successful nerve preservation.

## High Success in Tumor Removal and Nerve Preservation, But Not Hearing
The surgical results demonstrated a high degree of technical success in the primary goals of tumor removal and anatomical nerve preservation. Complete tumor excision was achieved in 92.30% of cases. More importantly, surgeons were able to preserve the anatomical continuity of the facial nerve in 87.50% of patients. This figure is critical because an intact nerve provides the physical pathway necessary for any potential functional recovery, which can occur over months or years.
The data on hearing, however, presented a stark contrast. Hearing preservation was achieved in only eight patients, representing just 6.2% of the study cohort. This low rate reflects the anatomical reality of large vestibular schwannomas, which typically engulf and stretch the cochlear nerve responsible for hearing. The study confirms that for large tumors, the primary surgical objective is almost always the preservation of facial nerve function and brainstem decompression, with hearing preservation being a secondary, and often unattainable, goal. For more on the complex relationship between hearing loss and related conditions, see our article on Mild Hearing Loss: Rethinking Tinnitus Impact.

## The Lasting Impact of Facial Nerve Dysfunction
The study concludes that postoperative facial nerve palsy is a significant and common complication of CPA vestibular schwannoma surgery. Due to the intimate anatomical relationship between the tumor and the seventh cranial (facial) nerve, surgical manipulation inherently carries risk. The resulting palsy can range from mild weakness (HB grade II) to complete paralysis (grade VI), directly impairing a patient’s ability to smile, close their eyelid, speak clearly, and control oral fluids. This has a profound effect on quality of life, social interaction, and mental well-being. The authors note that the incidence of this complication varies with tumor size, surgical technique, and surgeon experience, but it remains a central concern in every case. Our existing article on Facial Nerve Outcomes in Vestibular Schwannoma Surgery explores this topic in further detail.

## Practical Implications for Patient Care
The findings have clear implications for clinical practice and patient counseling. First, they support the retromastoid retrosigmoid sub-occipital approach as a safe and effective route for the primary microsurgical management of large vestibular schwannomas, particularly when patients already present with major neurological symptoms. Second, the data provide realistic benchmarks for outcomes: patients with large tumors can be counseled that while complete tumor removal and facial nerve preservation are highly probable, the chances of saving usable hearing are very low. Finally, the study reinforces the need for comprehensive postoperative rehabilitation, including physical therapy for facial muscles and eye care, to manage the effects of nerve palsy. Future advancements, such as those explored in robotic surgical systems, may offer even finer tools for dissection and nerve protection in this delicate area.

The research by Samadder and colleagues, published in the *Bangladesh Journal of Neurosurgery* (DOI: 10.3329/bjns.v14i2.89028), provides concrete, numbers-based evidence that guides expectations for one of the most challenging surgeries in neurotology.

💊 Related Supplements
Evidence-based options: zinc picolinate, magnesium glycinate

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts